Search

Tanya Kuritz

from Oak Ridge, TN
Age ~67
Get Report
Also known as:
Tanya T Sass, Tatiana Kuritz, Tanya Kurtiz, Kuritz Tanya, Lorraine Reardon
Related to:
Robert Eugene Knight, 72
Connected to:
Alyson S Kuritz, 38Carol G Kuritza, 61Matthew J Kuritz, 35Richard R Kuritz, 59William D Kuritz, 49Adam Kuritzky, 25Kevin A Kuritzky, 61Robert L Kuritzky, 104Brian Kuriyama, 37Mary L Kurjanowicz, 67

Tanya Kuritz Phones & Addresses

  • Oak Ridge, TN
  • Somerville, MA
  • Kingston, TN
  • Lansing, MI
  • Blue Ash, OH
  • Hamilton, OH
  • 126 Bradford Village Way, Kingston, TN 37763

Skills

Cell Biology • Lifesciences • Biofuels • Science

Industries

Biotechnology

Resumes

Resumes

Tanya Kuritz Photo 1

Tanya Kuritz

View page
Location:
Knoxville, Tennessee Area
Industry:
Biotechnology
Skills:
Cell Biology
Lifesciences
Biofuels
Science

Business Records

Name / Title
Company / Classification
Phones & Addresses
Tanya Kuritz
Genetics And Molecular Biology Researcher
Ut-Battelle, LLC
1 Bethel Vly Rd, Oak Ridge, TN 37830
(865) 576-2900, (865) 574-5812

Publications

Us Patents

Production Of Aligned Microfibers And Nanofibers And Derived Functional Monoliths

View page
US Patent:
7255781, Aug 14, 2007
Filed:
Sep 29, 2003
Appl. No.:
10/673719
Inventors:
Michael Z. Hu - Knoxville TN, US
David W. DePaoli - Knoxville TN, US
Tanya Kuritz - Kingston TN, US
Ogbemi Omatete - New Port Richey FL, US
Assignee:
UT-Battelle, LLC - Oak Ridge TN
International Classification:
G01N 27/453
US Classification:
204469, 204456
Abstract:
The present invention comprises a method for producing microfibers and nanofibers and further fabricating derived solid monolithic materials having aligned uniform micro- or nanofibrils. A method for producing fibers ranging in diameter from micrometer-sized to nanometer-sized comprises the steps of producing an electric field and preparing a solid precipitative reaction media wherein the media comprises at least one chemical reactive precursor and a solvent having low electrical conductivity and wherein a solid precipitation reaction process for nucleation and growth of a solid phase occurs within the media. Then, subjecting the media to the electric field to induce in-situ growth of microfibers or nanofibers during the reaction process within the media causing precipitative growth of solid phase particles wherein the reaction conditions and reaction kinetics control the size, morphology and composition of the fibers. The fibers can then be wet pressed while under electric field into a solid monolith slab, dried and consolidated.

Modulating Photoreactivity In A Cell

View page
US Patent:
20070259420, Nov 8, 2007
Filed:
May 29, 2007
Appl. No.:
11/754556
Inventors:
Elias Greenbaum - Knoxville TN, US
Tanya Kuritz - Kingston TN, US
Mark Humayun - Glendale CA, US
Assignee:
UT-BATTELLE, LLC - Oak Ridge TN
International Classification:
C12N 5/06
US Classification:
435325000
Abstract:
Photoreactivity in a cell is modulated by incorporating an isolated optical trigger on the surface or in the membrane of the cell. Exposure of a cell bearing incorporated optical triggers causes the generation of a measurable physiological signal.

Methods And Compositions For Modulation Of Innate Immunity

View page
US Patent:
20090306017, Dec 10, 2009
Filed:
Jun 6, 2008
Appl. No.:
12/157088
Inventors:
Tanya Kuritz - Kingston TN, US
International Classification:
A61K 31/66
A61P 37/00
US Classification:
514106, 514140
Abstract:
The present invention is directed towards a method of modulation of the innate immune of an organism system with the phosphorylated polyprenols of the present invention. The present invention is also directed towards a method of activation and/or modulation of the Toll-like Receptors with the phosphorylated polyprenols of the present invention. The present invention is also directed towards compound(s) comprising C35-C90 polyisoprenyls of Formula 1 and Formula 2 and their derivatives as well as methods of use of including activation and/or modulation of TLRs including TLR-2 and TLR-4 receptors and uses thereof including, e.g., use as antimicrobial, immunoregulatory, anti-cancer, cancer, for control of inflammatory conditions and as vaccine adjuvants.

Modulating Photoreactivity In A Cell

View page
US Patent:
20100267647, Oct 21, 2010
Filed:
Jun 28, 2010
Appl. No.:
12/824843
Inventors:
Elias Greenbaum - Knoxville TN, US
Tanya Kuritz - Kingston TN, US
Mark S. Humayun - Glendale CA, US
Assignee:
UT-BATTELLE, LLC - Oak Ridge TN
International Classification:
A61K 38/00
C12N 5/02
A61P 27/02
US Classification:
514 208, 435375
Abstract:
Photoreactivity in a cell is modulated by incorporating an isolated optical trigger on the surface or in the membrane of the cell. Exposure of a cell bearing incorporated optical triggers causes the generation of a measurable physiological signal.

Therapeutic Composition And Methods

View page
US Patent:
6525035, Feb 25, 2003
Filed:
Jun 10, 1999
Appl. No.:
09/329808
Inventors:
Leonid L. Danilov - Moscow, RU
Anna V. Deeva - Moscow, RU
Tanya Kuritz - Kingston TN
Sergei D. Maltsev - Moscow, RU
Alexander N. Narovlianskiy - Moscow, RU
Alexander V. Pronin - Moscow, RU
Alexander V. Sanin - Moscow, RU
Olga Y. Sosnovskaya - Moscow, RU
Sergei V. Ozherelkov - Moscow, RU
Assignee:
Sass Sass, Inc. - Kingston TN
International Classification:
A61K 3166
US Classification:
514106, 514143, 514134, 514102, 514 75
Abstract:
The invention provides composition comprising, 1) polyprenol monophosphates of the formula Hâ[âCH2-C(CH3) CHâCH2]n-OâP( O)(OH)2 wherein n is an integer from 6-19 inclusive or a salt thereof, and 2) polyprenol pyrophosphates of the formula Hâ[âCH2-C(CH3) CHâCH ] âOâP( O)(OH)âOâP( O)(OH) wherein m is an integer from 6-19 inclusive or a salt thereof, which is useful as an antiviral agent, as an immunomodulatory agent, and for treating cancer. The invention also provides pharmaceutical compositions comprising the compositions of the invention as well as therapeutic methods for using the the compositions.

Compositions And Methods For Immune Modulation Of Pathologic Inflammation

View page
US Patent:
20220288094, Sep 15, 2022
Filed:
Jun 9, 2021
Appl. No.:
17/343047
Inventors:
Tanya Kuritz - Kingston TN, US
John Patrick Biggerstaff - Banbury, GB
International Classification:
A61K 31/66
A61P 37/00
Abstract:
The invention describes modulating the innate immune response to pathogens by the compounds comprising C35-C90 polyisoprenyls of Formula 1 and Formula 2, as well as their derivatives, as well as methods of their use, including activation and or modulation of the integrins, including those with CD11b chain. Such modulation consists of the upregulation of integrins and attenuation of pathological inflammation in a disease while sustaining the innate antiviral response via Toll-receptors. This invention is directed towards using the above as antimicrobial, immunoregulatory, anti-cancer, anti-inflammatory treatments for humans and animals, including in diseases where pathological inflammation is caused by coronaviruses (SARS-CoV-2, FIPV), herpesviruses, and other agents.
Control profile
Tanya Kuritz from Oak Ridge, TN, age ~67 Get Report